JP2018520164A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520164A5 JP2018520164A5 JP2018500632A JP2018500632A JP2018520164A5 JP 2018520164 A5 JP2018520164 A5 JP 2018520164A5 JP 2018500632 A JP2018500632 A JP 2018500632A JP 2018500632 A JP2018500632 A JP 2018500632A JP 2018520164 A5 JP2018520164 A5 JP 2018520164A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- item
- bortezomib
- cancer
- melanoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562190563P | 2015-07-09 | 2015-07-09 | |
| US62/190,563 | 2015-07-09 | ||
| PCT/US2015/044662 WO2017007495A1 (en) | 2015-07-09 | 2015-08-11 | Methods of treating cancer by administering a mek inhibitor in combination with a proteasome inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018520164A JP2018520164A (ja) | 2018-07-26 |
| JP2018520164A5 true JP2018520164A5 (enExample) | 2018-09-06 |
Family
ID=57685946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018500632A Pending JP2018520164A (ja) | 2015-07-09 | 2015-08-11 | プロテアソームインヒビターと組み合わせてｍｅｋインヒビターを投与することによりがんを処置する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20180369203A1 (enExample) |
| JP (1) | JP2018520164A (enExample) |
| KR (1) | KR20180021198A (enExample) |
| AU (1) | AU2015401587A1 (enExample) |
| CA (1) | CA2991777A1 (enExample) |
| WO (1) | WO2017007495A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4087840A4 (en) | 2020-01-10 | 2024-01-10 | Immuneering Corporation | Mek inhibitors and therapeutic uses thereof |
| US20250099467A1 (en) * | 2022-01-25 | 2025-03-27 | Verastem, Inc. | Combination therapy for treating abnormal cell growth |
| CN115120731A (zh) * | 2022-07-12 | 2022-09-30 | 四川大学华西医院 | 一种靶向蛋白酶体治疗乳腺癌的药物应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2370568B1 (en) * | 2008-12-10 | 2017-07-19 | Dana-Farber Cancer Institute, Inc. | Mek mutations conferring resistance to mek inhibitors |
| US20130004481A1 (en) * | 2011-01-12 | 2013-01-03 | Boehringer Ingelheim International Gmbh | Anticancer therapy |
| US20150071918A1 (en) * | 2012-05-09 | 2015-03-12 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Peptides for the treatment of cancer |
| CN105163584B (zh) * | 2013-03-05 | 2019-06-04 | 田纳西大学研究基金会 | 用于治疗癌症的化合物 |
-
2015
- 2015-08-11 CA CA2991777A patent/CA2991777A1/en not_active Abandoned
- 2015-08-11 KR KR1020187003450A patent/KR20180021198A/ko not_active Withdrawn
- 2015-08-11 WO PCT/US2015/044662 patent/WO2017007495A1/en not_active Ceased
- 2015-08-11 JP JP2018500632A patent/JP2018520164A/ja active Pending
- 2015-08-11 US US15/742,725 patent/US20180369203A1/en not_active Abandoned
- 2015-08-11 AU AU2015401587A patent/AU2015401587A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Simmons et al. | Clinical management of pain in advanced lung cancer | |
| JP2014509657A5 (enExample) | ||
| RU2016112608A (ru) | Лечение рака комбинацией плинабулина и таксана | |
| JP2017505321A5 (enExample) | ||
| MX2022011334A (es) | Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert. | |
| MX383665B (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
| JP2012522837A5 (enExample) | ||
| PH12016502354A1 (en) | Pharmaceutical composition | |
| You et al. | Randomized clinical trial comparing efficacy of simo decoction and acupuncture or chewing gum alone on postoperative ileus in patients with hepatocellular carcinoma after hepatectomy | |
| JP2019532047A5 (enExample) | ||
| RU2015152785A (ru) | Лечение злокачественной опухоли налтрексоном | |
| MX2022011372A (es) | Composiciones de zinc-y-pga y metodos para tratar el cancer. | |
| JP2015527374A5 (enExample) | ||
| MX2011012491A (es) | Administracion continua de cilengitida en tratamientos contra el cancer. | |
| Leppert | The place of oxycodone/naloxone in chronic pain management | |
| WO2014115859A3 (ja) | 分子標的併用腫瘍治療・予防薬 | |
| RU2016143220A (ru) | Противоопухолевое средство, содержащее противоопухолевый комплекс платины, и усилитель противоопухолевого эффекта | |
| Grillo et al. | Targeted therapy in FLT3-ITD positive myeloid sarcoma: proof of principle | |
| Kim et al. | Outcomes of Concurrent Radiotherapy with Tarlatamab in Extensive-Stage Small Cell Lung Cancer from the DLL3 PanTUMOR Database | |
| JP2016502974A5 (enExample) | ||
| JP2019529554A5 (enExample) | ||
| MX2021001081A (es) | Terapia de combinacion para el tratamiento del cancer. | |
| Cupp et al. | A rare case of primary retroperitoneal mucinous adenocarcinoma: A case report | |
| RU2013135350A (ru) | Способ предупреждения болевых и психоэмоциональных реакций при эндоваскулярных рентгенхирургических вмешательствах | |
| Hata et al. | Dose reduction or intermittent administration of erlotinib: which is better for patients suffering from intolerable toxicities? |